Sanofi Consumer Healthcare India appoints Himanshu Bakshi as MD
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a statistically significant reduction in frequency and severity of vasomotor symptoms
The product is used to treat amyotrophic lateral sclerosis
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
2024 full-year revenue guidance raised by US$ 2 billion
Subscribe To Our Newsletter & Stay Updated